Literature DB >> 27798810

Emergence Delirium in Pediatric Anesthesia.

Arthura D Moore1, Doralina L Anghelescu2.   

Abstract

Emergence delirium (ED) is a complex of perceptual disturbances and psychomotor agitation that occurs most commonly in preschool-aged children in the early postanesthetic period. The incidence of ED varies between 10 and 80% in children and is perceived as a troublesome clinical situation by 42% of pediatric anesthesiologists. Although these events are often short lived, they increase the risk of self-injury and delayed discharge, require additional nursing staff and can increase medical care costs, all of which are causes for concern. The prevalence of ED has increased with the introduction and growing use of sevoflurane and desflurane, two low-solubility inhalational anesthetics. These agents promote early arousal post anesthetic, which contributes to ED. Physiological factors, pharmacological factors, the type of procedure, the anesthetic agent administered, painful stimuli, and various patient factors can all contribute to ED and thus need to be considered. Recent literature debates the cause-effect relationship between ED and pain, suggesting that they often occur concurrently but are sometimes independent findings. The consistent relation between ED and sevoflurane-based anesthesia has guided many studies to investigate its incidence compared with using other anesthetic techniques or various adjuncts. The risk of ED is lowest when propofol is used as a single-agent anesthetic compared with sevoflurane-based anesthetics. Adjunctive agents can be rated in the following order of most effective to least effective interventions: dexmedetomidine, fentanyl, ketamine, clonidine, and propofol bolus at the end of sevoflurane-based anesthesia. This review summarizes the factors that may predict ED and provides an intervention algorithm to guide effective prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27798810     DOI: 10.1007/s40272-016-0201-5

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  92 in total

1.  The prevention of emergence agitation with tropisetron or clonidine after sevoflurane anesthesia in small children undergoing adenoidectomy.

Authors:  Ulla Lankinen; Risto Avela; Pekka Tarkkila
Journal:  Anesth Analg       Date:  2006-05       Impact factor: 5.108

2.  The effect of intranasal fentanyl on the emergence characteristics after sevoflurane anesthesia in children undergoing surgery for bilateral myringotomy tube placement.

Authors:  J C Finkel; I T Cohen; R S Hannallah; K M Patel; M S Kim; K A Hummer; S S Choi; M Pena; S B Schreiber; G Zalzal
Journal:  Anesth Analg       Date:  2001-05       Impact factor: 5.108

3.  Family-centered preparation for surgery improves perioperative outcomes in children: a randomized controlled trial.

Authors:  Zeev N Kain; Alison A Caldwell-Andrews; Linda C Mayes; Megan E Weinberg; Shu-Ming Wang; Jill E MacLaren; Ronald L Blount
Journal:  Anesthesiology       Date:  2007-01       Impact factor: 7.892

4.  Tablet-based Interactive Distraction (TBID) vs oral midazolam to minimize perioperative anxiety in pediatric patients: a noninferiority randomized trial.

Authors:  Samuel C Seiden; Susan McMullan; Luis Sequera-Ramos; Gildasio S De Oliveira; Andrew Roth; Audrey Rosenblatt; Bill M Jesdale; Santhanam Suresh
Journal:  Paediatr Anaesth       Date:  2014-07-17       Impact factor: 2.556

5.  Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: a comparison with halothane.

Authors:  J Cravero; S Surgenor; K Whalen
Journal:  Paediatr Anaesth       Date:  2000       Impact factor: 2.556

6.  The perioperative dialogue reduces postoperative stress in children undergoing day surgery as confirmed by salivary cortisol.

Authors:  Berith Wennström; Carl-Johan Törnhage; Salmir Nasic; Hans Hedelin; Ingrid Bergh
Journal:  Paediatr Anaesth       Date:  2011-07-20       Impact factor: 2.556

7.  Comparison of caudal and intravenous clonidine in the prevention of agitation after sevoflurane in children.

Authors:  M Bock; P Kunz; R Schreckenberger; B M Graf; E Martin; J Motsch
Journal:  Br J Anaesth       Date:  2002-06       Impact factor: 9.166

8.  Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole.

Authors:  M Aho; O Erkola; A Kallio; H Scheinin; K Korttila
Journal:  J Clin Anesth       Date:  1993 May-Jun       Impact factor: 9.452

9.  Prevention of sevoflurane related emergence agitation in children undergoing adenotonsillectomy: A comparison of dexmedetomidine and propofol.

Authors:  Monaz Abdulrahman Ali; Ashraf Abualhasan Abdellatif
Journal:  Saudi J Anaesth       Date:  2013-07

10.  Delirium-biomarkers and genetic variance.

Authors:  Nicoleta Stoicea; Sean McVicker; Alexander Quinones; Priscilla Agbenyefia; Sergio D Bergese
Journal:  Front Pharmacol       Date:  2014-04-16       Impact factor: 5.810

View more
  25 in total

1.  Role of T-type Calcium Channels in Generating Hyperexcitatory Behaviors during Emergence from Sevoflurane Anesthesia in Neonatal Rats.

Authors:  Feng-Yan Shen; Byung-Gun Lim; Wen Wen; Yu Zhang; Bo Cao; Yue-Guang Si; Li-Qing Ma; Meng Deng; Yang In Kim; Young-Beom Kim; Ying-Wei Wang
Journal:  Neurosci Bull       Date:  2020-01-17       Impact factor: 5.203

2.  Effect of different administration and dosage of dexmedetomidine in the reduction of emergence agitation in children: a meta-analysis of randomized controlled trials with sequential trial analysis.

Authors:  Xu Zhang; Yan Bai; Min Shi; Shaopeng Ming; Xiaogao Jin; Yubo Xie
Journal:  Transl Pediatr       Date:  2021-04

3.  Perioperative dexmedetomidine reduces emergence agitation without increasing the oculocardiac reflex in children: A systematic review and meta-analysis.

Authors:  Jingyao Song; Shuyan Liu; Bin Fan; Guangyu Li; Qianchuang Sun
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

4.  Dexmedetomidine versus propofol on the sedation of pediatric patients during magnetic resonance imaging (MRI) scanning: a meta-analysis of current studies.

Authors:  Qiang Zhou; Lingli Shen; Xinxian Zhang; Jiong Li; Yong Tang
Journal:  Oncotarget       Date:  2017-11-01

5.  Factors associated with intravenous lidocaine in pediatric patients undergoing laparoscopic appendectomy - a retrospective, single-centre experience.

Authors:  Christian P Both; Jörg Thomas; Philipp K Bühler; Achim Schmitz; Markus Weiss; Tobias Piegeler
Journal:  BMC Anesthesiol       Date:  2018-07-18       Impact factor: 2.217

6.  End-Tidal Hypocapnia Under Anesthesia Predicts Postoperative Delirium.

Authors:  W Alan C Mutch; Renée El-Gabalawy; Linda Girling; Kayla Kilborn; Eric Jacobsohn
Journal:  Front Neurol       Date:  2018-08-17       Impact factor: 4.003

7.  Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial.

Authors:  Mengzhu Shi; Shuai Miao; Tianchu Gu; Dongyue Wang; Hui Zhang; Jindong Liu
Journal:  Drug Des Devel Ther       Date:  2019-03-15       Impact factor: 4.162

8.  The prevalence of emergence delirium and its associated factors among children at a postoperative unit: A retrospective cohort at a Middle Eastern hospital.

Authors:  Sadal K Aldakhil; Mahmoud Salam; Areej A Albelali; Raghad M Alkanhal; Maram J Alnemer; Abdulaleem Alatassi
Journal:  Saudi J Anaesth       Date:  2020-03-05

9.  Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?

Authors:  Muge O Korkmaz; Havva Sayhan; Mehmet Guven
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

10.  Effects of peri-operative intravenous administration of dexmedetomidine on emergence agitation after general anesthesia in adults: a meta-analysis of randomized controlled trials.

Authors:  Jian Zhang; Yang Yu; Shuai Miao; Lu Liu; Shuyuan Gan; Xianhui Kang; Shengmei Zhu
Journal:  Drug Des Devel Ther       Date:  2019-08-15       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.